Questions and answers about   MASLD 

Understanding MASLD

  1. What is MASLD?
    MASLD stands for Metabolic Dysfunction-Associated Steatotic Liver Disease. It occurs when excess fat builds up in the liver in a person who has at least one cardiometabolic risk factor.

  2. What was MASLD previously called?
    It was previously commonly called nonalcoholic fatty liver disease (NAFLD).

  3. Why was NAFLD renamed MASLD?
    Medical organizations adopted new terminology intended to describe the metabolic causes of the disease more accurately and reduce stigmatizing language.

  4. What does "steatotic" mean?
    Steatotic refers to an abnormal accumulation of fat in an organ. In MASLD, that organ is the liver.

  5. Is MASLD a type of fatty liver disease?
    Yes. MASLD is a major form of steatotic liver disease associated with metabolic risk factors.

  6. Is MASLD common?
    Yes. It is one of the most common chronic liver conditions worldwide.

  7. Is MASLD contagious?
    No. You cannot catch MASLD from another person.

  8. Is MASLD inherited?
    MASLD itself is not inherited in a simple way, but genetics can influence a person's susceptibility.

  9. Can MASLD occur in families?
    Yes. Shared genetics, eating patterns, activity levels, and metabolic risk factors can contribute to MASLD occurring in multiple family members.

  10. Can someone have MASLD without knowing it?
    Yes. Many people have no obvious symptoms, particularly during the early stages.

Causes and Risk Factors

  1. What causes MASLD?
    MASLD develops through a combination of metabolic dysfunction, genetics, environmental factors, diet, physical activity, and other influences.

  2. Is obesity a risk factor for MASLD?
    Yes. Overweight and obesity, particularly excess abdominal fat, are important risk factors.

  3. Can a person who is not overweight develop MASLD?
    Yes. MASLD can occur in people who have a normal body weight.

  4. Is type 2 diabetes associated with MASLD?
    Yes. Type 2 diabetes is one of the strongest risk factors for MASLD and advanced liver fibrosis.

  5. Does insulin resistance contribute to MASLD?
    Yes. Insulin resistance plays an important role in the development and progression of metabolic liver disease.

  6. Can high blood pressure increase MASLD risk?
    High blood pressure is one of the cardiometabolic risk factors associated with MASLD.

  7. Are abnormal cholesterol levels associated with MASLD?
    Yes. Abnormal blood lipids frequently occur alongside MASLD.

  8. Are high triglycerides associated with MASLD?
    Yes. Elevated triglycerides are commonly associated with metabolic dysfunction and fatty liver.

  9. Can metabolic syndrome increase the risk of MASLD?
    Yes. MASLD is strongly associated with metabolic syndrome and its components.

  10. Does age affect MASLD risk?
    MASLD can occur at any age, but the risk of advanced disease generally increases with age and duration of metabolic risk factors.

  11. Can children develop MASLD?
    Yes. MASLD is an important cause of chronic liver disease in children and adolescents.

  12. Can genetics increase MASLD risk?
    Yes. Variants in genes such as PNPLA3 can influence susceptibility and disease progression.

  13. Can poor nutrition contribute to MASLD?
    Diets that contribute to excess calorie intake and metabolic dysfunction can increase risk.

  14. Can sugary beverages contribute to metabolic problems associated with MASLD?
    Frequent consumption of sugar-sweetened beverages can contribute to excess calorie intake, weight gain, and metabolic dysfunction.

  15. Does physical inactivity increase the risk of MASLD?
    A sedentary lifestyle can contribute to obesity, insulin resistance, and other metabolic risk factors.

MASLD and Alcohol

  1. Does MASLD mean a person never drinks alcohol?
    Not necessarily. The current classification considers both metabolic risk factors and alcohol exposure.

  2. Can alcohol make liver disease worse in someone with MASLD?
    Yes. Alcohol may increase liver injury and fibrosis risk, particularly at higher levels of consumption.

  3. What is MetALD?
    MetALD describes steatotic liver disease in people who have metabolic dysfunction and consume alcohol within a defined range above the MASLD category.

  4. Should people with MASLD drink alcohol?
    Alcohol recommendations should be individualized. People with advanced fibrosis or cirrhosis are generally advised to avoid alcohol.

  5. Should patients tell their doctors how much alcohol they consume?
    Yes. Accurate information helps clinicians classify liver disease and recommend safer care.

Symptoms

  1. What are the symptoms of MASLD?
    Many people have no symptoms. When symptoms occur, fatigue or discomfort in the upper-right abdomen may be reported.

  2. Can MASLD cause fatigue?
    Yes, although fatigue has many possible causes and is not specific to MASLD.

  3. Can MASLD cause abdominal discomfort?
    Some people experience discomfort or fullness in the upper-right abdomen.

  4. Can MASLD cause jaundice?
    Jaundice is uncommon in uncomplicated early MASLD but can occur when advanced liver disease develops.

  5. Can MASLD cause abdominal swelling?
    Advanced cirrhosis can cause fluid accumulation in the abdomen, known as ascites.

  6. Can MASLD cause swollen legs?
    Advanced liver disease can contribute to swelling in the legs and ankles.

  7. Can MASLD cause itching?
    Itching can occur in liver disease but is not a typical early symptom of MASLD.

  8. Can someone have severe MASLD without symptoms?
    Yes. Significant fibrosis may develop before noticeable symptoms appear.

  9. Does the absence of pain mean the liver is healthy?
    No. Many chronic liver diseases cause little or no pain.

  10. When should someone with possible MASLD seek medical evaluation?
    Anyone with abnormal liver tests, metabolic risk factors, or concerns about liver health should discuss appropriate evaluation with a healthcare professional.

Diagnosis and Testing

  1. How is MASLD diagnosed?
    Diagnosis generally involves medical history, evidence of liver steatosis, assessment of cardiometabolic risk factors, blood tests, and sometimes imaging or additional testing.

  2. Can blood tests diagnose MASLD by themselves?
    No. Blood tests are useful, but diagnosis and risk assessment usually require additional clinical information.

  3. What liver enzymes are commonly checked?
    ALT and AST are commonly measured.

  4. Can MASLD exist with normal ALT and AST levels?
    Yes. Normal liver enzymes do not rule out MASLD or significant fibrosis.

  5. Can ultrasound detect fatty liver?
    Conventional ultrasound can detect moderate-to-severe liver fat but may miss mild steatosis.

  6. What is elastography?
    Elastography is a noninvasive method used to estimate liver stiffness, which can help assess fibrosis.

  7. What is FibroScan?
    FibroScan is a brand of transient elastography that can measure liver stiffness and estimate liver fat.

  8. What is FIB-4?
    FIB-4 is a noninvasive fibrosis-risk calculation using age, AST, ALT, and platelet count.

  9. Why is fibrosis assessment important?
    The amount of liver fibrosis is one of the strongest predictors of liver-related complications in MASLD.

  10. Does everyone with MASLD need a liver biopsy?
    No. Noninvasive tests can assess many patients, while biopsy is reserved for selected situations.

  11. What can a liver biopsy show?
    It can show liver fat, inflammation, liver-cell injury, and the amount of fibrosis.

  12. Can CT scans detect liver fat?
    CT imaging can sometimes identify steatosis but is not usually the preferred method solely for screening because of radiation exposure and other limitations.

  13. Can MRI measure liver fat?
    Yes. Specialized MRI techniques can accurately quantify liver fat.

  14. How often should MASLD be monitored?
    Monitoring frequency depends on fibrosis risk, metabolic conditions, age, treatment, and other individual factors.

  15. Who may need referral to a liver specialist?
    People with suspected advanced fibrosis, cirrhosis, persistently abnormal liver tests, uncertain diagnoses, or other concerning findings may need hepatology evaluation.

MASH and Fibrosis

  1. What is MASH?
    MASH stands for Metabolic Dysfunction-Associated Steatohepatitis, a more active form of metabolic liver disease involving steatosis, inflammation, and liver-cell injury.

  2. What was MASH previously called?
    It was previously known as nonalcoholic steatohepatitis (NASH).

  3. Does everyone with MASLD develop MASH?
    No. Only a portion of people with MASLD develop MASH.

  4. What is liver fibrosis?
    Fibrosis is the formation of scar tissue in response to ongoing liver injury.

  5. Can MASLD cause fibrosis?
    Yes. Some people with MASLD develop progressively increasing fibrosis.

  6. Can fibrosis improve?
    Yes. Fibrosis can improve in some people when the underlying liver injury and metabolic risk factors are successfully treated.

  7. What is cirrhosis?
    Cirrhosis is advanced liver scarring that changes the liver's normal structure and can impair its function.

  8. Can MASLD cause cirrhosis?
    Yes. Progressive MASH and fibrosis can eventually lead to cirrhosis.

  9. Does everyone with MASH develop cirrhosis?
    No. Progression varies considerably among individuals.

  10. Why is advanced fibrosis dangerous?
    It increases the risk of liver failure, portal hypertension, liver cancer, and other serious complications.

Treatment and Lifestyle

  1. Can MASLD be treated?
    Yes. Treatment focuses on improving metabolic health, reducing liver fat and inflammation, preventing fibrosis progression, and managing associated conditions.

  2. Can weight loss improve MASLD?
    Yes. For people with overweight or obesity, sustained weight loss can reduce liver fat and may improve inflammation and fibrosis.

  3. How much weight loss can help?
    Even modest weight loss can reduce liver fat, while larger sustained losses—often around 7–10% or more—may provide greater improvement in MASH and fibrosis for appropriate patients.

  4. Should weight loss be gradual?
    Sustainable weight management under appropriate medical guidance is generally preferred to extreme or unproven diets.

  5. Can exercise help even without major weight loss?
    Yes. Regular physical activity can reduce liver fat and improve metabolic and cardiovascular health even when weight loss is limited.

  6. What kinds of exercise are helpful?
    Aerobic activity and resistance training can both be beneficial.

  7. How much exercise should adults aim for?
    Many guidelines recommend at least 150 minutes of moderate-intensity physical activity per week, adjusted for a person's abilities and medical conditions.

  8. Is resistance training useful?
    Yes. Strength training can improve muscle health and metabolic fitness.

  9. What eating pattern is often recommended for MASLD?
    A Mediterranean-style eating pattern is commonly recommended because of its metabolic and cardiovascular benefits.

  10. What foods are emphasized in a Mediterranean-style diet?
    Vegetables, fruits, whole grains, legumes, nuts, fish, and unsaturated fats are commonly emphasized.

  11. Should sugary drinks be limited?
    Yes. Limiting sugar-sweetened beverages can reduce excess sugar and calorie intake.

  12. Should highly processed foods be limited?
    Reducing foods high in added sugars, refined carbohydrates, saturated fats, and excess calories can support metabolic health.

  13. Can coffee be beneficial?
    Regular coffee consumption has been associated with a lower risk of fibrosis and some liver complications in observational research, when coffee is otherwise safe for the individual.

  14. Do liver detoxes cure MASLD?
    No. Commercial detoxes and cleanses have not been proven to cure MASLD.

  15. Can supplements cure MASLD?
    No supplement should be considered a universal cure, and some supplements can injure the liver or interact with medications.

Medications and Medical Management

  1. Are medications available specifically for MASH?
    Yes. In the United States, medications have been approved for certain adults with MASH and moderate-to-advanced fibrosis, and treatment options continue to evolve.

  2. What is resmetirom?
    Resmetirom is a thyroid hormone receptor-beta agonist approved in the United States for certain adults with noncirrhotic MASH and moderate-to-advanced fibrosis, alongside diet and exercise.

  3. What is semaglutide used for in liver disease?
    Semaglutide, a GLP-1 receptor agonist, has an FDA-approved indication for certain adults with MASH and moderate-to-advanced fibrosis, in addition to its uses for other conditions.

  4. Can diabetes medications help people with MASLD?
    Some diabetes medications can improve weight and metabolic health and may provide liver benefits in appropriate patients.

  5. Can cholesterol medications be used in MASLD?
    Yes. Statins are generally considered safe in people with MASLD when clinically indicated and are important for reducing cardiovascular risk.

  6. Why is cardiovascular health important in MASLD?
    Cardiovascular disease is a major cause of illness and death among people with MASLD.

  7. Should diabetes be carefully managed?
    Yes. Good diabetes management can reduce cardiovascular and metabolic risks and is an important part of MASLD care.

  8. Should high blood pressure be treated?
    Yes. Blood-pressure management is important for overall cardiovascular and metabolic health.

  9. Should high cholesterol be treated?
    Yes. Appropriate lipid management can reduce cardiovascular risk.

  10. Should MASLD treatment be individualized?
    Yes. Treatment should consider fibrosis stage, diabetes, body weight, cardiovascular risk, medications, age, and other health conditions.

Complications, Prevention, and Outlook

  1. Can MASLD increase the risk of liver cancer?
    Yes. The risk is particularly increased in people who develop advanced fibrosis or cirrhosis.

  2. What type of liver cancer is associated with MASLD?
    Hepatocellular carcinoma (HCC) is the primary liver cancer of greatest concern.

  3. Do people with MASLD need liver-cancer screening?
    Not everyone does. Regular HCC surveillance is generally recommended for people with cirrhosis and may be considered in selected high-risk situations.

  4. Can MASLD cause liver failure?
    Advanced MASLD-related cirrhosis can eventually lead to liver failure.

  5. Can MASLD lead to liver transplantation?
    Yes. Advanced metabolic liver disease is an important reason people may eventually require liver transplantation.

  6. Can MASLD be prevented?
    Not every case can be prevented, but maintaining metabolic health, staying physically active, managing body weight, and controlling diabetes, blood pressure, and cholesterol can reduce risk.

  7. Can children with MASLD develop serious liver disease?
    Yes. Pediatric MASLD can progress, making early identification and management of metabolic risk factors important.

  8. Can MASLD improve over time?
    Yes. Liver fat, inflammation, and sometimes fibrosis can improve with effective treatment and sustained metabolic improvements.

  9. What is one of the most important facts about MASLD?
    MASLD can remain silent for years, so people with metabolic risk factors may need assessment even when they feel healthy.

  10. What should someone do if they think they have MASLD?
    They should discuss their risk factors with a healthcare professional. Appropriate evaluation may include blood tests and noninvasive fibrosis assessment to determine whether liver fat or significant scarring is present.